Filter
823
Filtered Results: 823
Text search:
antibody
tests
Featured
Recommendations
120
New Publications
207
Language
Document type
No document type
427
Guidelines
194
Studies & Reports
84
Manuals
45
Fact sheets
35
Strategic & Response Plan
14
Training Material
10
Resource Platforms
5
Situation Updates
4
Infographics
3
Brochures
1
Videos
1
Countries / Regions
India
73
Global
38
South Africa
28
Tanzania
19
Zambia
14
Western and Central Europe
14
Africa
14
Nepal
13
Latin America and the Carribbean
13
Ethiopia
12
Kenya
12
East and Southern Africa
12
Nigeria
11
Malawi
10
West and Central Africa
10
Germany
9
Sierra Leone
8
Philippines
8
Rwanda
8
Middle East and North Africa
8
Russia
8
Uganda
7
Eastern Europe
7
Ghana
6
Bangladesh
6
Liberia
5
Brazil
5
Cameroon
4
Zimbabwe
4
Mozambique
4
Namibia
4
Myanmar / Burma
4
Eastern Europe and Central Asia
4
USA
3
Cambodia
3
Ukraine
3
Madagascar
3
Lesotho
3
South–East Asia Region
3
Asia
3
Burkina Faso
2
Congo, Democratic Republic of
2
South Sudan
2
China
2
Indonesia
2
Peru
2
Colombia
2
Botswana
2
Angola
2
Venezuela
2
Tajikistan
2
North America
2
France
2
Guinea
1
Senegal
1
Mali
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Niger
1
Haiti
1
Pakistan
1
Turkey
1
Syria
1
Benin
1
Argentina
1
Eswatini/ Swaziland
1
Bolivia
1
Chile
1
Yemen
1
Italy
1
Albania
1
Southern Africa
1
Congo-Brazzaville
1
Kazakhstan
1
Georgia
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
287
Clinical Guidelines
143
Pharmacy & Technologies
40
Public Health
36
Women & Child Health
22
Capacity Building
14
Key Resources
12
Toolboxes
COVID-19
144
HIV
116
Rapid Response
64
NTDs
63
Zika
25
TB
22
Ebola
21
NCDs
15
Refugee
14
Mental Health
14
Pharmacy
12
AMR
8
Planetary Health
8
Caregiver
7
Polio
6
Cholera
4
Natural Hazards
2
Conflict
1
Global Health Education
1
Health Financing Toolbox
1
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
WHO/HTM/HIV/2007.01 WHO/HTM/TB/2007.380
WHO/CDS/CSR/EDC/99.2 Plague Manual
Epidemiology, Distribution, Surveillance and Control
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Cervical cancer, along with maternal deaths, has been identified as a national priority in
South Africa as well as other Sub-Saharan African countries. Cervical cancer is the
second most common cancer among women in South Africa, after breast cancer. Due
to limited access to prevention, early dia...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te...
This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market. The next steps taken to include these new innovati...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also inter...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. ...
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interwe...
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document on management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and re...
Prepared as an outcome of ICMR Subcommittee on Multiple Myeloma | This consensus document on management of multiple myeloma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also i...
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molec...
The present DHR-ICMR guidelines comprehensively address the various concerns regarding the clinical assessment, treatment, and laboratory diagnosis of rickettsial diseases in India and the world. It is hoped that physicians, health care workers, the scientific community, the regulatory agencies, pub...
